Jordan is a strategically significant Levant market with a GDP exceeding $50 billion and a population of approximately 10 million. Despite its modest domestic market size, Jordan punches well above its weight as a regional hub for healthcare, pharmaceutical manufacturing, and professional services — making it an indispensable node for MENA-wide research strategies. Its proximity to Iraq, Saudi Arabia, and Palestinian markets, combined with a highly educated and Arabic-English bilingual workforce, makes Jordan a preferred base for Levant research programmes.
The Jordan Food and Drug Administration (JFDA) is the primary regulatory body overseeing pharmaceutical registration, food safety, and medical device approvals. Research supporting product registration, market access, or formulary inclusion in Jordan must align with JFDA guidelines. Jordan is also home to a thriving generic pharmaceutical manufacturing sector — represented by the Jordan Generic Pharmaceutical Manufacturers Association — producing for domestic consumption and export across the wider MENA region. This manufacturing strength generates sustained demand for competitive intelligence, prescription audit, and healthcare professional survey research.
The King Hussein Cancer Center (KHCC) and other Jordanian academic medical institutions provide a strong foundation for clinical and health outcomes research. For consumer and FMCG research, Jordan's increasingly urban, young, and digitally connected population creates demand for brand health tracking, shopper insights, and digital consumer studies. The right market research partner must combine JFDA regulatory awareness, Levant fieldwork capability, and Arabic-English bilingual delivery with a genuine understanding of Jordan's unique role at the intersection of GCC, Levant, and North African markets.